Disclosure - Responsible Transparency / 2022
Disclosures by KEFEA Members:
(Also click on the following hyperlink for the Methodological note)
(Also click on the following hyperlink for the Methodological note)
(Also click on the following hyperlink for the Methodological note) – Represented by ALECTOR PHARMACEUTICALS
(Also click on the following hyperlink for the Methodology statement)
(Also click on the following hyperlink for the Methodological note)
(Also click on the following hyperlink for the Methodological note)
(Also click on the following hypelink for the Methodological note)
(Also click on the following hyperlink for the Methodological note)
Also click on the following hyperlink for the Methodological note)
Disclosures by other EFPIA members operating in Cyprus*:
- LIFEPHARMA (Z.A.M.) LTD representing ABBVIE
- G.A. STAMATIS & CO. LTD representing Roche (Hellas) S.A.
- C.G. PAPALOISOU representing Merck
- C.G. PAPALOISOU representing Other
- CPO Ltd representing Boehringer Ingelheim
- Varnavas Hadjipanayis Ltd representing Janssen Pharmaceuticals
- Varnavas Hadjipanayis Ltd representing Novo Nordisk
- Varnavas Hadjipanayis Ltd representing CSL
- Lundbeck Hellas S.A
* Hypertext links in this section of the website will direct you to websites containing the disclosure of transfers of value as required by the KEFEA Code of Conduct. These websites are not under the control of KEFEA. When you activate any of these, you will leave this website. KEFEA accepts no responsibility or liability for the accuracy of the content of any such websites and makes no representation or warranty (express or implied) as to the information contained therein.’’